Atossa Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Atossa Therapeutics generated cash of -$20,941, which is more than the previous year. Cash used in financing activities reached the amount of -$1,475 last year. Net change in cash is therefore -$22,430.
Cash Flow
| 2014 | -10.55M | -343.25K | 13.05M |
|---|---|---|---|
| 2015 | -13.95M | -288.41K | 9.45M |
| 2016 | -5.37M | -9.21K | 4.69M |
| 2017 | -6.59M | 0 | 10.78M |
| 2018 | -8.96M | -110.90K | 12.29M |
| 2019 | -9.12M | -7.62K | 11.33M |
| 2020 | -11.57M | -9.36K | 38.55M |
| 2021 | -16.47M | -9K | 113.30M |
| 2022 | -20.76M | -4.72M | 0 |
| 2023 | -20.94K | -14 | -1.47K |
ATOS Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 111K | 136.48M | 39.66M | 12.69M | 10.49M | 7.27M | 3.02M | 3.71M | 8.50M | 6.34M |
Operating activities | ||||||||||
Net income | -30.09M | -26.96M | -20.60M | -17.82M | -17.23M | -11.40M | -8.12M | -6.36M | -12.75M | -14.65M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 23K | 8K | 23K | 46.52K | 52.78K | 44.19K | 128.99K | 303.48K | 272.62K | 564.45K |
Stock-based compensation expense | 4.62M | 6.78K | 5.26M | 3.01M | 8.84M | 0 | 786.55K | 876.18K | 840.10K | 698.65K |
| Deferred income tax benefit | 4.62M | 6.78K | 5.26M | 3.01M | 8.84M | 0 | 786.55K | 876.18K | 840.10K | 698.65K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 743K | 329K | -437K | 104.71K | -221.55K | -159.82K | -358.27K | 0 | 321.05K | -368.17K |
Inventories | 2.54M | -329K | 437K | -104.71K | 221.55K | 0 | 0 | 0 | 9.27K | -39.78K |
Accounts payable | -2.15M | 1.24M | 128K | 1.29M | -60.15K | 18.42K | 80.58K | -560.12K | 301.40K | 346.21K |
Cash generated by operating activities | -20.94K | -20.76M | -16.47M | -11.57M | -9.12M | -8.96M | -6.59M | -5.37M | -13.95M | -10.55M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -4.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -14 | -27K | -9K | -9.36K | -7.62K | -110.90K | 0 | -9.21K | -130.73K | -343.25K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -14 | -4.72M | -9K | -9.36K | -7.62K | -110.90K | 0 | -9.21K | -288.41K | -343.25K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 113.87M | 33.61M | 11.33M | 12.29M | 10.03M | 4.69M | 9.45M | 13.15M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -1.47M | 0 | -573 | -14K | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -14K | 0 | 0 | 0 | 0 | 0 | -98.48K |
Cash used in financing activities | -1.47K | 0 | 113.30M | 38.55M | 11.33M | 12.29M | 10.78M | 4.69M | 9.45M | 13.05M |
Net Change In Cash | -22.43K | -25.48M | 96.82M | 26.97M | 2.20M | 3.21M | 4.18M | -687.93K | -4.78M | 2.15M |
Cash at end of period | 88.57K | 111M | 136.48M | 39.66M | 12.69M | 10.49M | 7.21M | 3.02M | 3.71M | 8.50M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |